Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association.

Gastroenterology. 2006 Mar;130(3):940-87. Review. No abstract available.

PMID:
16530532
2.

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association.

Gastroenterology. 2006 Mar;130(3):935-9. No abstract available.

PMID:
16530531
3.

[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].

Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W.

Rev Gastroenterol Mex. 2006 Jul-Sep;71(3):351-401. Review. Spanish. No abstract available.

PMID:
17140062
4.

Pharmacogenetics of inflammatory bowel disease.

Katsanos KH, Papadakis KA.

Pharmacogenomics. 2014 Dec;15(16):2049-62. doi: 10.2217/pgs.14.154. Review.

PMID:
25521361
5.

[Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].

Rogler G.

Dtsch Med Wochenschr. 2008 Sep;133(38):1917-21. doi: 10.1055/s-0028-1085577. Epub 2008 Sep 10. Review. German. No abstract available.

6.

Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen.

Vincenti F.

Transplant Proc. 2001 Jun;33(4 Suppl):11S-18S. No abstract available.

PMID:
11406263
7.

[Crohn's disease--standards of treatment 2004].

Kruis W.

Praxis (Bern 1994). 2005 Oct 12;94(41):1595-8. Review. German.

PMID:
16245637
8.

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.

Panaccione R, Rutgeerts P, Sandborn WJ, Feagan B, Schreiber S, Ghosh S.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):674-88. doi: 10.1111/j.1365-2036.2008.03753.x. Review.

9.

Efficacy of conventional immunosuppressive drugs in IBD.

Caprilli R, Angelucci E, Cocco A, Viscido A, Zippi M.

Dig Liver Dis. 2004 Nov;36(11):766-80. Review.

PMID:
15571009
10.

A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.

Sandborn WJ.

Am J Gastroenterol. 1996 Mar;91(3):423-33. Review. No abstract available.

PMID:
8633486
11.

Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease.

Ben-Horin S, Waterman M, Kopylov U, Yavzori M, Picard O, Fudim E, Awadie H, Weiss B, Chowers Y.

Clin Gastroenterol Hepatol. 2013 Apr;11(4):444-7. doi: 10.1016/j.cgh.2012.10.020. Epub 2012 Oct 24.

PMID:
23103905
12.

Pharmacogenetics and inflammatory bowel disease: progress and prospects.

Ho GT, Lees C, Satsangi J.

Inflamm Bowel Dis. 2004 Mar;10(2):148-58. Review. No abstract available.

PMID:
15168816
13.

[Chronically active Crohn's disease].

Hoffmann J, Zeitz M; German Society for Digestive and Metabolic Diseases.

Z Gastroenterol. 2003 Jan;41(1):31-5. German. No abstract available.

PMID:
12541171
14.

Drug resistance in inflammatory bowel diseases.

Moreau J, Mas E.

Curr Opin Pharmacol. 2015 Dec;25:56-61. doi: 10.1016/j.coph.2015.11.003. Epub 2015 Nov 29. Review.

PMID:
26645664
15.

General principles of medical therapy of inflammatory bowel disease.

Friedman S.

Gastroenterol Clin North Am. 2004 Jun;33(2):191-208, viii. Review.

PMID:
15177534
16.

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients.

Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR.

Gastroenterology. 2003 Aug;125(2):320-7.

PMID:
12891531
17.

The role and advances of immunomodulator therapy for inflammatory bowel disease.

Nielsen OH, Coskun M, Steenholdt C, Rogler G.

Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):177-89. doi: 10.1586/17474124.2014.945914. Epub 2014 Aug 7. Review.

PMID:
25101818
18.

Effects and treatment of inflammatory bowel disease during pregnancy.

Brar H, Einarson A.

Can Fam Physician. 2008 Jul;54(7):981-3.

19.

Balancing efficacy and toxicity in kidney-transplant immunosuppression.

Leichtman AB.

N Engl J Med. 2007 Dec 20;357(25):2625-7. No abstract available.

PMID:
18094383
20.

Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.

Bousvaros A.

Expert Rev Clin Immunol. 2010 Jul;6(4):659-66. doi: 10.1586/eci.10.46. Review.

PMID:
20594138

Supplemental Content

Support Center